Russia supplies Covid-19 vaccine to Belarus for clinical trials

Russia has sent a first batch of its Sputnik V COVID-19 vaccine to Belarus for clinical trials, the first such delivery of the jab abroad, Russian sovereign wealth fund RDIF said on Monday.

MOSCOW, Sept 28 (Reuters) - Russia has sent a first batch of its Sputnik V COVID-19 vaccine to Belarus for clinical trials, the first such delivery of the jab abroad, Russian sovereign wealth fund RDIF said on Monday.

Volunteers in Belarus would begin receiving the Russian vaccine from Oct. 1, the Russian Direct Investment Fund which is backing the vaccine developer, said.

(Reporting by Maria Kiselyova and Polina Ivanova; writing by Tom Balmforth; Editing by Alex Richardson)

((Tom.Balmforth@thomsonreuters.com))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More